Research programme: beta-amyloid ligands - Affibody
Alternative Names: Affibody® molecules; Aβ ligands - Affibody; Beta-amyloid ligands - AffibodyLatest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator Affibody
- Class Recombinant fusion proteins
- Mechanism of Action Amyloid beta-protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Alzheimer's-disease in Sweden
- 27 Mar 2008 Preclinical development is ongoing
- 19 May 2005 Preclinical trials in Alzheimer's disease in Sweden (unspecified route)